Levine PH, Steinhorn SC, Ries LG, Aron JL (1985) Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program. J Natl Cancer Inst
Margoles RG, Fisher B, Hortobagyi H, Bloomer WG (2000) Neoplasms of the breast. In: Bast RC, Kufe DW, Pollock RE, Weichselbaum RR, Holland JF, Frei E, eds. Cancer Medicine, 5th edn. Hamilton, Ontario: B.C. Decker Inc.
Jaiyesimi IA, Buzdar AU, Hortobagyi G (1992) Inflammatory breast cancer: a review. J Clin Oncol
Chang S, Parker SL, Pham T, Buzdar AU, Hursting SD (1998) Inflammatory breast carcinoma incidence and survival, the surveillance, epidemiology, and end results program of the National Cancer Institute, 1975-1992. Cancer
Taylor G, Meltzer A (1938) Inflammatory carcinoma of the breast. Am J Cancer
Haagensen C (1971) Diseases of the Breast, 2nd edn. Philadelphia, PA: Saunders, pp. 576–584.
Singletary SE, Ames FC, Buzdar AU (1994) Management of inflammatory breast cancer. World J Surg
Bonnier P, Charpin C, Lejeune C, et al.
(1995) Inflammatory carcinomas of the breast: a clinical pathological, or a clinical and pathological definition? Int J Cancer
Dahlbeck SW, Donnelly JF, Theriault RL (1995) Differentiating inflammatory breast cancer from acute mastitis. Am Fam Physician
Brooks HL, Mandava N, Pizzi W, Shah S (1998) Inflammatory breast carcinoma: a community hospital experience. Am College Surgeons
Percy C, Van Holten V, Muir C, eds. (1990) International Classification of Diseases for Oncology, 2nd edn. Geneva, Switzerland: World Health Organization.
Chang S, Buzdar AU, Hursting SD (1998) Inflammatory breast cancer and body mass index. J Clin Oncol
SEER*Stat 2001(2003) Bethesda, MD: National Cancer Institute. Also available from: URL: http://seer.cancer.gov/seerstat [accessed 2003, January 13].
Fay MP, Feuer EJ (1997) Confidence intervals for directly standardized rates: a method based on the gamma distribution. Statist Med
Ries LAG, Eisner MP, Kosary CL, et al. eds. (2002) SEER Cancer Statistics Review, 1973-1999. Bethesda, MD: National Cancer Institute. Also available from: URL: http://www.seer.cancer.gov/csr/1973_1999 [accessed 2002, June 14].
Katz D, Baptista J, Azen SP, Pike MC (1978) Obtaining confidence intervals for the risk ratio in cohort studies. Biometrics
O'Malley C, Hu KU, West DW (2002) North American association of central cancer registries: race and ethnicity identifier assessment project. Also available from: URL http://www.naaccr.org, http://www.naaccr.org/Training/files [accessed August 2002].
Ries LAG, Eisner MP, Kosary CL, et al. eds. (2001) SEER Cancer Statistics Review, 1973-1998. Bethesda, MD: National Cancer Institute.
Greene FL, Page DL, Fleming ID, et al. eds. (2002) AJCC Cancer Staging Manual, 6th edn. New York: Springer-Verlag, pp. 221–240.
US Cancer Statistics Working Group (2002) United States Cancer Statistics: 1999 Incidence. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute.
Rosenberg HM, Maurer JD, Sorlie PD, et al.(1999) Quality of death rates by race and Hispanic origin: a summary of current research. Vital Health Stat
Poe GS, Powell-Griner E, McLaughlin JK, Placek PJ, Thompson GB, Robinson K (1993) Comparability of the Death Certificate and the 1986 National Mortality Followback Survey. Hyattsville, MD: National Center for Health Statistics.
Kolonel LH, Goodman MT (1992) Racial variation in cancer: fact or artifact? J Natl Cancer Inst
Hogan H (1993) The 1990 post-enumeration survey: operations and results. J Am Stat Assoc